Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS at NTRA
- Sold, on record
- $43.9M
- Dollars the filings state
- Form 4 sales
- 51
- Latest Oct 1, 2026
- Form 144 notices
- 27
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NTRANatera, Inc.PRESIDENT, CLINICALDIAGNOSTICS
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice NTRANoticeAug 3, 2026 2026
Filed to sell 3,000 shares ($796k)
Moshkevich Solomon, Officer
10b5-1 plan1x usual sizeFiling
- 2 Form 144 notice NTRANoticeAug 3, 2026 same day
Filed to sell 405 shares ($108k)
Moshkevich Solomon, OFFICER
No 10b5-1 plan0.1x usual sizeFiling
- 3 Form 4 sale NTRARoutineAug 3, 2026 same day
Sold 3,410 shares at $265.58 ($906k)
Moshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS
10b5-1 planSold 2.6% of holdings ($35.2M position)129,019 shares left1.1x usual sizeFollows a Form 144Filing
- 4 Form 144 notice NTRANoticeSep 1, 2026 +29 days
Filed to sell 3,000 shares ($962k)
Moshkevich Solomon, Officer
10b5-1 plan1x usual sizeFiling
- 5 Form 144 notice NTRANoticeSep 2, 2026 +1 day
Filed to sell 0 shares ($0)
Moshkevich Solomon, OFFICER
No 10b5-1 plan0x usual sizeFiling
- 6 Form 4 sale NTRAUnusualSep 2, 2026 same day
Sold 18,160 shares at $325.87 ($5.9M)
Moshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS
10b5-1 planSold 14.1% of holdings ($42M position)110,859 shares left6.1x usual sizeFollows a Form 144Filing
- 7 Form 144 notice NTRANoticeOct 1, 2026 +29 days
Filed to sell 3,000 shares ($1.2M)
Moshkevich Solomon, Officer
10b5-1 plan1x usual sizeFiling
- 8 Form 4 sale NTRARoutineOct 1, 2026 same day
Sold 3,000 shares at $414.22 ($1.2M)
Moshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS
10b5-1 planSold 2.7% of holdings ($45.5M position)106,914 shares left1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (78)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Oct 2, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,000 | $1.2M | 2.7% | Routine | SEC |
| Oct 1, 2026 | Oct 1, 2026 | NTRA | Officer | Form 144 notice | 3,000 | $1.2M | Notice | SEC | |
| Sep 2, 2026 | Sep 3, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 18,160 | $5.9M | 14.1% | Unusual | SEC |
| Sep 2, 2026 | Sep 2, 2026 | NTRA | OFFICER | Form 144 notice | 0 | $0 | Notice | SEC | |
| Sep 1, 2026 | Sep 1, 2026 | NTRA | Officer | Form 144 notice | 3,000 | $962k | Notice | SEC | |
| Aug 3, 2026 | Aug 5, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,410 | $906k | 2.6% | Routine | SEC |
| Aug 3, 2026 | Aug 3, 2026 | NTRA | OFFICER | Form 144 notice | 405 | $108k | Notice | SEC | |
| Aug 3, 2026 | Aug 3, 2026 | NTRA | Officer | Form 144 notice | 3,000 | $796k | Notice | SEC | |
| Jul 28, 2026 | Jul 29, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 2,214 | $569k | 1.6% | Routine | SEC |
| Jul 28, 2026 | Jul 28, 2026 | NTRA | OFFICER | Form 144 notice | 1,185 | $306k | Notice | SEC | |
| Jul 27, 2026 | Jul 27, 2026 | NTRA | OFFICER | Form 144 notice | 998 | $261k | Notice | SEC | |
| Jul 1, 2026 | Jul 6, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,000 | $819k | 2.2% | Routine | SEC |
| Jul 1, 2026 | Jul 1, 2026 | NTRA | Officer | Form 144 notice | 3,000 | $819k | Notice | SEC | |
| Jun 1, 2026 | Jun 3, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,000 | $655k | 2.1% | Routine | SEC |
| Jun 1, 2026 | Jun 1, 2026 | NTRA | Officer | Form 144 notice | 3,000 | $655k | Notice | SEC | |
| May 26, 2026 | May 28, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 1,652 | $335k | 1.2% | Routine | SEC |
| May 1, 2026 | May 5, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,405 | $694k | 2.3% | Routine | SEC |
| May 1, 2026 | May 1, 2026 | NTRA | Officer | Form 144 notice | 3,000 | $610k | Notice | SEC | |
| Apr 27, 2026 | Apr 29, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 2,182 | $445k | 1.5% | Routine | SEC |
| Apr 1, 2026 | Apr 3, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,000 | $607k | 2.0% | Routine | SEC |
| Apr 1, 2026 | Apr 1, 2026 | NTRA | Officer | Form 144 notice | 3,000 | $607k | Notice | SEC | |
| Mar 10, 2026 | Mar 11, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 915 | $187k | 0.6% | Routine | SEC |
| Mar 2, 2026 | Mar 3, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,000 | $600k | 2.0% | Routine | SEC |
| Mar 2, 2026 | Mar 2, 2026 | NTRA | Officer | Form 144 notice | 3,000 | $600k | Notice | SEC | |
| Feb 3, 2026 | Feb 4, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 4,639 | $1.1M | 3.3% | Routine | SEC |
| Feb 2, 2026 | Feb 2, 2026 | NTRA | Officer | Form 144 notice | 3,000 | $694k | Notice | SEC | |
| Jan 28, 2026 | Jan 29, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 2,213 | $529k | 1.5% | Routine | SEC |
| Jan 21, 2026 | Jan 22, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 23,498 | $5.5M | 14.0% | Unusual | SEC |
| Jan 2, 2026 | Jan 6, 2026 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 2,951 | $676k | 2.3% | Routine | SEC |
| Jan 2, 2026 | Jan 2, 2026 | NTRA | Officer | Form 144 notice | 2,951 | $676k | Notice | SEC | |
| Dec 12, 2025 | Dec 16, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 4,692 | $1.1M | 4.0% | No plan | SEC |
| Dec 12, 2025 | Dec 12, 2025 | NTRA | Officer | Form 144 notice | 4,692 | $1.1M | Notice | SEC | |
| Dec 1, 2025 | Dec 3, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,000 | $714k | 2.7% | Routine | SEC |
| Dec 1, 2025 | Dec 1, 2025 | NTRA | Officer | Form 144 notice | 3,000 | $714k | Notice | SEC | |
| Nov 3, 2025 | Nov 4, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,000 | $596k | 2.6% | Routine | SEC |
| Nov 3, 2025 | Nov 3, 2025 | NTRA | Officer | Form 144 notice | 3,000 | $596k | Notice | SEC | |
| Oct 28, 2025 | Oct 29, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 2,206 | $423k | 1.9% | Routine | SEC |
| Oct 21, 2025 | Oct 22, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 292 | $55k | 0.2% | Routine | SEC |
| Oct 1, 2025 | Oct 1, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,000 | $480k | 2.5% | Routine | SEC |
| Oct 1, 2025 | Oct 1, 2025 | NTRA | Officer | Form 144 notice | 3,000 | $480k | Notice | SEC | |
| Sep 2, 2025 | Sep 5, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,000 | $500k | 2.4% | Routine | SEC |
| Sep 2, 2025 | Sep 2, 2025 | NTRA | Officer | Form 144 notice | 3,000 | $500k | Notice | SEC | |
| Aug 14, 2025 | Aug 15, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 875 | $136k | 0.7% | Routine | SEC |
| Aug 1, 2025 | Aug 5, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,000 | $399k | 2.4% | Routine | SEC |
| Aug 1, 2025 | Aug 1, 2025 | NTRA | Officer | Form 144 notice | 3,000 | $399k | Notice | SEC | |
| Jul 28, 2025 | Jul 30, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 2,206 | $308k | 1.7% | Routine | SEC |
| Jul 21, 2025 | Jul 22, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 1,940 | $299k | 1.5% | Routine | SEC |
| Jul 1, 2025 | Jul 3, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,000 | $500k | 2.3% | Routine | SEC |
| Jul 1, 2025 | Jul 1, 2025 | NTRA | Officer | Form 144 notice | 3,000 | $500k | Notice | SEC | |
| Jun 2, 2025 | Jun 4, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,000 | $471k | 2.2% | Routine | SEC |
| Jun 2, 2025 | Jun 2, 2025 | NTRA | Officer | Form 144 notice | 3,000 | $471k | Notice | SEC | |
| May 1, 2025 | May 2, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,000 | $450k | 2.2% | Routine | SEC |
| May 1, 2025 | May 1, 2025 | NTRA | Officer | Form 144 notice | 3,000 | $450k | Notice | SEC | |
| Apr 28, 2025 | Apr 30, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 2,206 | $336k | 1.6% | Routine | SEC |
| Apr 21, 2025 | Apr 22, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 296 | $43k | 0.2% | Routine | SEC |
| Apr 1, 2025 | Apr 3, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,000 | $421k | 2.1% | Routine | SEC |
| Apr 1, 2025 | Apr 1, 2025 | NTRA | Officer | Form 144 notice | 3,000 | $421k | Notice | SEC | |
| Mar 17, 2025 | Mar 19, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 1,026 | $150k | 0.7% | Routine | SEC |
| Mar 5, 2025 | Mar 7, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 6,000 | $860k | 4.0% | Unusual | SEC |
| Mar 5, 2025 | Mar 5, 2025 | NTRA | Officer | Form 144 notice | 6,000 | $860k | Notice | SEC | |
| Feb 6, 2025 | Feb 7, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 1,632 | $290k | 1.1% | Routine | SEC |
| Jan 29, 2025 | Jan 31, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 5,201 | $863k | 3.7% | Unusual | SEC |
| Jan 22, 2025 | Jan 24, 2025 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 24,861 | $4.1M | 15.0% | Unusual | SEC |
| Dec 23, 2024 | Dec 26, 2024 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 2,428 | $388k | 2.0% | Routine | SEC |
| Dec 9, 2024 | Dec 11, 2024 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 4,858 | $809k | 4.1% | Routine | SEC |
| Dec 9, 2024 | Dec 10, 2024 | NTRA | Officer | Form 144 notice | 4,858 | $809k | Notice | SEC | |
| Oct 28, 2024 | Oct 30, 2024 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 1,196 | $141k | 1.1% | Routine | SEC |
| Oct 22, 2024 | Oct 23, 2024 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 550 | $66k | 0.5% | Routine | SEC |
| Jul 29, 2024 | Jul 31, 2024 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 1,196 | $123k | 1.1% | Routine | SEC |
| Jul 22, 2024 | Jul 23, 2024 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 549 | $58k | 0.5% | Routine | SEC |
| May 28, 2024 | May 30, 2024 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 1,647 | $181k | 1.4% | Routine | SEC |
| Apr 29, 2024 | May 1, 2024 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 1,196 | $111k | 1.0% | Routine | SEC |
| Apr 23, 2024 | Apr 23, 2024 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 531 | $49k | 0.5% | Routine | SEC |
| Apr 16, 2024 | Apr 17, 2024 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 80,000 | $7.3M | 40.5% | Unusual | SEC |
| Apr 16, 2024 | Apr 16, 2024 | NTRA | Officer | Form 144 notice | 80,000 | $7.3M | Notice | SEC | |
| Mar 28, 2024 | Mar 29, 2024 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 707 | $64k | 0.4% | Routine | SEC |
| Mar 5, 2024 | Mar 7, 2024 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 2,245 | $198k | 1.1% | No plan | SEC |
| Jan 29, 2024 | Jan 30, 2024 | NTRA | PRESIDENT, CLINICALDIAGNOSTICS | Form 4 sale | 3,426 | $223k | 1.7% | No plan | SEC |